Some studies have reported decreased CAT activity in the granulocyte lysates of MS patients, while others have shown increased CAT activity in the cerebrospinal fluid and serum of patients with RRMS and CIS compared to the control group. This evidence concerns the gene CAT and relapsing-remitting multiple sclerosis.